Avita Medical Inc (RCEL) financials
Avita Medical revenue and earnings by year
Avita Medical's revenue was $71.6 million in the fiscal year to December 31, 2025, up 11.5% from the year before. Net income was -$48.6 million, -67.8% of revenue. Since the fiscal year to December 31, 2021, revenue has grown 19.9% a year on average.
Fiscal years, each labelled by the calendar year it ended in.
Income statement, the last 5 fiscal years
| Fiscal year to | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
| Revenue | 72 | 64 | 52 | 38 | 35 |
| Revenue growth | 11.5% | 24.6% | 37.0% | 8.7% | — |
| Gross profit | 59 | 55 | 44 | 32 | 29 |
| Gross margin | 82.1% | 85.8% | 84.9% | 83.9% | 82.4% |
| Operating income | -43 | -57 | -43 | -28 | -25 |
| Operating margin | -59.4% | -88.1% | -82.7% | -73.1% | -72.6% |
| Net income | -49 | -62 | -35 | -27 | -25 |
| Net margin | -67.8% | -96.3% | -68.6% | -70.8% | -72.6% |
| Diluted EPS | -$1.74 | -$2.39 | -$1.40 | — | — |
| Free cash flow | -33 | -58 | -39 | -20 | -6 |
Diluted EPS is stated in today's shares (adjusted for every split since). Quarterly statements and the income statement as a flow chart are in the app: open RCEL in Markets.
See also: RCEL returns
No forecast, no recommendation. This page describes Avita Medical Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.